BIOMAT Database Logo BIOMAT Database Logo

Antiviral Activity of 7-Substituted 7-Deazapurine Ribonucleosides, Monophosphate Prodrugs, and Triphoshates against Emerging RNA Viruses. 2021

Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16000 Prague 6, Czech Republic.

A series of 7-deazaadenine ribonucleosides bearing alkyl, alkenyl, alkynyl, aryl, or hetaryl groups at position 7 as well as their 5'-O-triphosphates and two types of monophosphate prodrugs (phosphoramidates and S-acylthioethanol esters) were prepared and tested for antiviral activity against selected RNA viruses (Dengue, Zika, tick-borne encephalitis, West Nile, and SARS-CoV-2). The modified triphosphates inhibited the viral RNA-dependent RNA polymerases at micromolar concentrations through the incorporation of the modified nucleotide and stopping a further extension of the RNA chain. 7-Deazaadenosine nucleosides bearing ethynyl or small hetaryl groups at position 7 showed (sub)micromolar antiviral activities but significant cytotoxicity, whereas the nucleosides bearing bulkier heterocycles were still active but less toxic. Unexpectedly, the monophosphate prodrugs were similarly or less active than the corresponding nucleosides in the in vitro antiviral assays, although the bis(S-acylthioethanol) prodrug 14h was transported to the Huh7 cells and efficiently released the nucleoside monophosphate.

UI MeSH Term Description Entries
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D003716 Dengue Virus A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known. Breakbone Fever Virus,Breakbone Fever Viruses,Dengue Viruses,Fever Virus, Breakbone,Fever Viruses, Breakbone,Virus, Breakbone Fever,Virus, Dengue,Viruses, Breakbone Fever,Viruses, Dengue
D004669 Encephalitis Viruses, Tick-Borne A subgroup of the genus FLAVIVIRUS that causes encephalitis and hemorrhagic fevers and is found in eastern and western Europe and the former Soviet Union. It is transmitted by TICKS and there is an associated milk-borne transmission from viremic cattle, goats, and sheep. Hemorrhagic Fever Virus, Omsk,Kyasanur Forest disease virus,Langat virus,Louping ill virus,Omsk hemorrhagic fever virus,Powassan virus,Al-Khurma Hemorrhagic Fever Virus,Al-Khurma virus,Al-Khurma virus (ALKV),Alkhurma Hemorrhagic Fever Virus,Alkhurma virus,Alkhurma virus (ALKV),Encephalitis Virus, Tick-Borne,Tick-Borne Encephalitis Virus,Tick-Borne Encephalitis Viruses,Viruses, Tick-Borne Encephalitis,Al Khurma Hemorrhagic Fever Virus,Al Khurma virus,Al Khurma virus (ALKV),Encephalitis Virus, Tick Borne,Encephalitis Viruses, Tick Borne,Louping ill viruses,Tick Borne Encephalitis Virus,Tick Borne Encephalitis Viruses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071244 Zika Virus An arbovirus in the FLAVIVIRUS genus of the family FLAVIVIRIDAE. Originally isolated in the Zika Forest of UGANDA it has been introduced to Asia and the Americas. Virus, Zika,ZikV
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19

Related Publications

Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Synthesis of 7-trifluoromethyl-7-deazapurine ribonucleoside analogs and their monophosphate prodrugs.
January 2020, Nucleosides, nucleotides & nucleic acids,
Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Synthesis, cytostatic, antimicrobial, and anti-HCV activity of 6-substituted 7-(het)aryl-7-deazapurine ribonucleosides.
February 2014, Journal of medicinal chemistry,
Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Synthesis and Cytostatic and Antiviral Profiling of Thieno-Fused 7-Deazapurine Ribonucleosides.
March 2017, Journal of medicinal chemistry,
Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
2-Substituted 6-(Het)aryl-7-deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity.
June 2015, ChemMedChem,
Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Synthesis and Cytotoxic and Antiviral Profiling of Pyrrolo- and Furo-Fused 7-Deazapurine Ribonucleosides.
October 2018, Journal of medicinal chemistry,
Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Synthesis and Cytotoxic and Antiviral Activity Profiling of All-Four Isomeric Series of Pyrido-Fused 7-Deazapurine Ribonucleosides.
October 2020, Chemistry (Weinheim an der Bergstrasse, Germany),
Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Correction to "Synthesis and Cytotoxic and Antiviral Profiling of Pyrrolo- and Furo-Fused 7-Deazapurine Ribonucleosides".
February 2019, Journal of medicinal chemistry,
Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Phosphoramidate pronucleotides of cytostatic 6-aryl-7-deazapurine ribonucleosides.
January 2011, Bioorganic & medicinal chemistry,
Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Dual N6/C7-Substituted 7-Deazapurine and Tricyclic Ribonucleosides with Affinity for G Protein-Coupled Receptors.
January 2024, ACS medicinal chemistry letters,
Nemanja Milisavljevic, and Eva Konkolová, and Jaroslav Kozák, and Jan Hodek, and Lucia Veselovská, and Veronika Sýkorová, and Karel Čížek, and Radek Pohl, and Luděk Eyer, and Pavel Svoboda, and Daniel Růžek, and Jan Weber, and Radim Nencka, and Evžen Bouřa, and Michal Hocek
Synthesis and Antitrypanosomal Activity of 6-Substituted 7-Methyl-7-deazapurine Nucleosides.
April 2021, ACS infectious diseases,
Copied contents to your clipboard!